Related Experiment Videos
Targeted Epigenetic Silencing of Jumonji Domain-Containing Protein 3 Alleviates Nuclear Factor-Kappa B-Mediated
Ghada Nour Eldeen1, Mona F Sokkar1, Randa S Lotfy1
1Molecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Centre, Egypt.
Background:
Familial Mediterranean fever (FMF) is an inherited autoinflammatory condition caused by variants in the MEFV gene encoding pyrin, the essential component of the NLRP3/NF-κB complex of inflammasomes. Deregulation of nuclear factor-kappa B (NF-κB), a key proinflammatory mediator, leads to chronic inflammation in autoinflammatory/autoimmune diseases. Epigenetic modulation offers a new approach to regulate inflammasome activity, with Jumonji domain-containing protein 3 (JMJD3) being a promising target for managing inflammatory illnesses. GSK-J4 is a selective inhibitor of JMJD3, restricting pro-inflammatory cytokines and inflammation.
Aim:
Our research aimed to elucidate the role of JMJD3 and the NF-κB-JMJD3 signaling pathways in regulating inflammation in an in vitro model, and to investigate GSK-J4's effect in inhibiting inflammasome activation in primed peripheral blood mononuclear cells (PBMCs) isolated from FMF cases.
Methods:
PBMCs were cultured and primed with LPS, and then treated with GSK-J4. JMJD3 knockdown was achieved using siRNA interference. Cellular inflammatory dynamics were assessed by Western blotting (WB) and ELISA. The qRT-PCR was used for gene expression quantification. Untreated cells served as a negative control.
Results:
Our results showed significantly downregulated gene expression of NF-κB, NLRP3, and inflammatory cytokines in GSK-J4-treated cells compared to untreated cells, as confirmed by ELISA. WB reported a reduction of NF-κB in induced cells following GSK-J4 treatment. Knocking down JMJD3 also showed decreased levels of JMJD3, NF-κB, and inflammatory cytokines, indicating its proinflammatory role.
Conclusion:
The study showed that selective inhibition or silencing of JMJD3 significantly suppressed the inflammasome in FMF cases, suggesting its role as a therapeutic target for alleviating inflammation in various autoinflammatory diseases.
Insights
In Familial Mediterranean Fever (FMF), inhibiting JMJD3 with GSK-J4 suppressed inflammasome activation and reduced key inflammatory markers. This highlights JMJD3 as a potential therapeutic target for autoinflammatory diseases.
Area of Science:
- Inflammation research
- Molecular biology
- Genetics
Background:
- Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease linked to MEFV gene variants and inflammasome dysregulation.
- Nuclear factor-kappa B (NF-κB) is a key mediator of chronic inflammation in autoinflammatory conditions.
- Jumonji domain-containing protein 3 (JMJD3) is an epigenetic regulator implicated in inflammation, with its inhibitor GSK-J4 showing potential therapeutic benefits.
Purpose of the Study:
- To investigate the role of JMJD3 and NF-κB-JMJD3 signaling in inflammation.
- To evaluate the efficacy of GSK-J4 in inhibiting inflammasome activation in FMF patient cells.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from FMF patients were cultured and stimulated.
- Cells were treated with GSK-J4 or subjected to JMJD3 knockdown via siRNA.
- Inflammatory markers and gene expression were analyzed using Western blotting, ELISA, and qRT-PCR.
Main Results:
- GSK-J4 treatment significantly downregulated NF-κB, NLRP3, and inflammatory cytokine gene expression.
- Western blotting confirmed reduced NF-κB levels post-GSK-J4 treatment.
- JMJD3 knockdown also decreased inflammatory markers, confirming its pro-inflammatory role.
Conclusions:
- Selective inhibition or silencing of JMJD3 effectively suppresses inflammasome activation in FMF.
- JMJD3 represents a promising therapeutic target for managing inflammation in FMF and other autoinflammatory diseases.
Related Concept Videos
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...